HIV Infection: Drugs

(asked on 4th December 2017) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what steps he is taking to ensure the availability of Pre-Exposure Prophylaxis (PrEP) for people with HIV in areas of high HIV prevalence after the places on the PrEP impact trial are fully subscribed.


Answered by
Steve Brine Portrait
Steve Brine
This question was answered on 7th December 2017

The planning assumptions that underpin the Pre-Exposure Prophylaxis (PrEP) IMPACT trial will offer a reasonable opportunity to participate to those assessed as meeting the eligibility criteria for the trial and willing to take PrEP. The availability of PrEP is in the context of a clinical trial with 10,000 participants which has been designed to answer important research questions to inform future commissioning and rollout plans. There will be opportunities as the trial progresses to consider re-allocating places between sites should it prove necessary to meet demand.

Further information can be found on the PrEP IMPACT trial website at:

www.prepimpacttrial.org.uk

Reticulating Splines